[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000045804A3 - Prevention de la formation d'abces - Google Patents

Prevention de la formation d'abces Download PDF

Info

Publication number
WO2000045804A3
WO2000045804A3 PCT/US2000/002988 US0002988W WO0045804A3 WO 2000045804 A3 WO2000045804 A3 WO 2000045804A3 US 0002988 W US0002988 W US 0002988W WO 0045804 A3 WO0045804 A3 WO 0045804A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
abscess formation
polyanionic polysaccharide
polysaccharide solution
solution
Prior art date
Application number
PCT/US2000/002988
Other languages
English (en)
Other versions
WO2000045804A2 (fr
Inventor
James W Burns
Eugene Skrabut
Goor Harry Van
Michel M P J Reijnen
Original Assignee
Genzyme Corp
Univ Hospital Nijmegen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Univ Hospital Nijmegen filed Critical Genzyme Corp
Priority to AU33566/00A priority Critical patent/AU3356600A/en
Priority to CA002361572A priority patent/CA2361572A1/fr
Priority to EP00911708A priority patent/EP1148886A2/fr
Priority to JP2000596924A priority patent/JP2002536323A/ja
Publication of WO2000045804A2 publication Critical patent/WO2000045804A2/fr
Publication of WO2000045804A3 publication Critical patent/WO2000045804A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

L'invention concerne un procédé relatif à la prévention ou à la réduction de la gravité de la formation d'un abcès chez l'homme, qui consiste à utiliser une solution diluée de polysaccharide polyanionique, et de préférence une solution d'acide hyaluronique ou de carboxyméthylcellulose, en application au tissu sur le site d'une procédure chirurgicale.
PCT/US2000/002988 1999-02-04 2000-02-04 Prevention de la formation d'abces WO2000045804A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU33566/00A AU3356600A (en) 1999-02-04 2000-02-04 Prevention of abscess formation
CA002361572A CA2361572A1 (fr) 1999-02-04 2000-02-04 Prevention de la formation d'abces
EP00911708A EP1148886A2 (fr) 1999-02-04 2000-02-04 Prevention de la formation d'abces
JP2000596924A JP2002536323A (ja) 1999-02-04 2000-02-04 膿瘍形成の予防

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11870799P 1999-02-04 1999-02-04
US60/118,707 1999-02-04

Publications (2)

Publication Number Publication Date
WO2000045804A2 WO2000045804A2 (fr) 2000-08-10
WO2000045804A3 true WO2000045804A3 (fr) 2001-03-08

Family

ID=22380260

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/002988 WO2000045804A2 (fr) 1999-02-04 2000-02-04 Prevention de la formation d'abces

Country Status (5)

Country Link
EP (1) EP1148886A2 (fr)
JP (1) JP2002536323A (fr)
AU (1) AU3356600A (fr)
CA (1) CA2361572A1 (fr)
WO (1) WO2000045804A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002154906A (ja) 2000-11-13 2002-05-28 Michio Hayashi 抗菌剤組成物
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
JP5039552B2 (ja) * 2005-08-04 2012-10-03 帝人株式会社 セルロース誘導体
RU2486892C1 (ru) * 2011-11-25 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального обучения "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО "ХГУ им. Н.Ф.Катанова") Способ лимфотропной терапии при ортодентальных абсцессах у кроликов

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004058A2 (fr) * 1989-09-21 1991-04-04 Norpharmco Inc. Traitement de maladies et d'etats pathologiques
JPH09208476A (ja) * 1996-01-26 1997-08-12 Takada Seiyaku Kk 腹腔内投与用医薬組成物
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004058A2 (fr) * 1989-09-21 1991-04-04 Norpharmco Inc. Traitement de maladies et d'etats pathologiques
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
JPH09208476A (ja) * 1996-01-26 1997-08-12 Takada Seiyaku Kk 腹腔内投与用医薬組成物

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BURNS, J.W. ET AL: "Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions", JOURNAL OF SURGICAL RESEARCH, vol. 59, no. 6, - 1995, pages 644 - 652, XP000952895 *
DATABASE EMBASE ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; XP002151239 *
FOSCHI, D. ET AL: "Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats", INTERNATIONAL JOURNAL OF TISSUE REACTIONS, vol. 12, no. 6, 1990, pages 333 - 339, XP000953074 *
MUELLER, P.O.E. ET AL: "Intraperitoneal use of sodium carboxymethylcellulose in horses undergoing exploratory celiotomy", VETERINARY SURGERY, vol. 24, no. 2, 1995, pages 112 - 117, XP000953146 *
NARAMA, I. ET AL: "26-week chronic toxicity study and 5-week recovery test of high molecular weight sodium hyaluronate (NRD101) in rats by intraperitoneal administration", JAPANESE PHARMACOLOGY AND THERAPEUTICS, vol. 22, no. SUPPL. 3, 1994, pages 93 - 134 *
ONDERDONK, A.B. ET AL: "Immunomodulatory effects of derivatized hyaluronic acid-carboxymethylcellulose gels (DHA) in an animal model for intraabdominal sepsis", ABSTRACTS OF THE 99TH GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 99, 1 June 1999 (1999-06-01), pages 11, XP000953083 *
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 12 (C - ) 25 December 1997 (1997-12-25) *
PECK, L.S. ET AL: "Evaluation of CMC and HA solutions for adhesiolysis", JOURNAL OF INVESTIGATIVE SURGERY, vol. 8, 1995, pages 337 - 348, XP000953093 *
REIJNEN, M.M. ET AL: "Prevention of intraabdominal abscesses and adhesions using a hyaluronic acid solution in a rat peritonitis model", ARCHIVES OF SURGERY, vol. 134, no. 9, September 1999 (1999-09-01), pages 997 - 1001, XP000952881 *
TZIANABOS, A.O. ET AL: "Structure and function of Bacteroides fragilis capsular polysaccharides: Relationship to induction and prevention of abscesses", CLINICL INFECTIOUS DISEASES, vol. 20, no. suppl. 2, 1995, pages S132 - S140, XP000952888 *
YAACOBI, Y. ET AL: "Prevention of postoperative abdominal adhesions by tissue precoating with polymer solutions", JOURNAL OF SURGICAL RESEARCH, vol. 55, no. 4, October 1993 (1993-10-01), pages 422 - 426, XP000952885 *

Also Published As

Publication number Publication date
EP1148886A2 (fr) 2001-10-31
JP2002536323A (ja) 2002-10-29
WO2000045804A2 (fr) 2000-08-10
CA2361572A1 (fr) 2000-08-10
AU3356600A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
WO2002018448A3 (fr) Polysaccharides percaboxyles, et procede d'elaboration
AU2264801A (en) Surgical prosthesis
EP0815879A3 (fr) Dispositifs médicaux biorésorbables en polysaccharides oxidés
CA2390556A1 (fr) Utilisation de derives de cellulose solubles rendus difficilement solubles dans l'eau et methode de preparation de ces derives
WO2000051566A8 (fr) Procede d'attenuation de cicatrice
CA2194462A1 (fr) Agent activant la regeneration de tissu dur
WO2001000190A3 (fr) Utilisation de derives d'acide hyaluronique dans des preparations pharmaceutiques et des biomateriaux destines a la prevention et au traitement des cicatrices cutanees
WO2001044489A3 (fr) Oligosaccharides de glactomannane, procedes de fabrication et utilisations de ces composes
AU2457301A (en) Water insoluble derivatives of polyanionic polysaccharides
EP0956869A3 (fr) Agent de scellement tissulaire
NZ290218A (en) Composition to reduce adhesion in wound healing
AU752280C (en) Conjugate of therapeutic agent for joint disease and hyaluronic acid.
AU3077299A (en) Method of promoting production of living tissue equivalents
WO2001024783A3 (fr) Utilisation de (+)-tramadol, de o-demethyltramadol ou de (+)-o-demethyltramadol, de o-desmethyle-n-mono-desmethyl-tramadol ou de (+)o-desmethyl-n-mono-desmethyl-tramadol pour traiter l'incontinence urinaire
WO2000045804A3 (fr) Prevention de la formation d'abces
WO1999049854A3 (fr) Utilisation de dexmedetomidine pour la sedation dans une unite de soins intensifs
AU6630101A (en) Chest piece for stethoscopes, and methods of utilizing stethoscopes for monitoring the physiological conditons of patient
AU2001246510A1 (en) Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
BR0012661A (pt) Métodos de tratamento e métodos de triagem de drogas
CA2369275A1 (fr) Procede de preparation de composes autoreticules d'acide hyaluronique et de derives de ces derniers a l'aide de la technique d'antisolvent supercritique
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
NO20005492L (no) Dekstrinholdig preparat for prevensjon av kirurgiske adhesjoner
WO2000059940A3 (fr) Gene et proteine lies au facteur de croissance d'origine plaquettaire
AU1522101A (en) Heparanase inhibitors for the treatment of heart failure
CA2375743A1 (fr) Methodes et compositions de support, de regeneration et de reparation des tissus conjonctifs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 33566/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000911708

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2361572

Country of ref document: CA

Ref country code: CA

Ref document number: 2361572

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 596924

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000911708

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000911708

Country of ref document: EP